International Webinar on ESWT in Men’s Health – April 2026

Focus of the Training

The training focused on ED, CPPS, Peyronie’s disease, patient assessment, treatment planning, safety, and interdisciplinary collaboration. The focus was on both the technical execution and the reasoning involved before and after the treatment itself. When I teach, my goal is for participants to be able to explain why a particular treatment is chosen, for whom it is appropriate, and when a different approach is more relevant.

Why this is relevant to a patient’s journey

At Peyronie’s disease and newly developed curvature The clinical assessment is at least as important as the choice of treatment itself. Plaque, calcification, pain, stability, erectile quality, and the degree of curvature should be evaluated as a whole. It is precisely this type of differentiation that makes it possible to explain to the patient what shockwave therapy can and cannot realistically be expected to change. In cases of CP/CPPS and chronic pelvic pain, the patient’s journey is often long because the symptoms can stem from multiple structures and mechanisms simultaneously. The pelvic floor, nerves, connective tissue, pain regulation, urinary symptoms, and sexual activity may all be interrelated. The training therefore supports a broader assessment in which shockwave therapy or EMTT is not used in isolation but is selected based on the clinical picture.

I therefore use teaching as an ongoing professional quality assessment of my own clinical model. When I have to explain my choice of technology and indication to other clinicians, both the strengths and limitations become clearer.

From Education to Clinical Quality

When education takes place on an international scale, differences in practice become apparent: which patients are referred, how they are examined, which devices are available, and how results are evaluated. This variation is valuable because it serves as a reminder that sound clinical decisions should not rely on a single manufacturer, a single protocol, or a single explanatory model.

Another important element is managing expectations. In areas such as sexual function, chronic pain, and incontinence, two patients with the same diagnosis may have vastly different causes and prognoses. Therefore, it is important to be precise about which problem is being addressed, how progress is measured, and when a lack of response should lead to a reassessment rather than simply continuing with the same treatment.

I also emphasize the importance of distinguishing between mechanism, clinical evidence, and marketing. The fact that a technology can biologically affect tissue does not mean that it has a documented effect on all indications. Conversely, clinical evidence may be relevant without being directly transferable between different devices, doses, or patient groups. This distinction is crucial both in teaching and in conversations with patients.

It is the professional connection between education and clinical practice that I want these educational activities to demonstrate: not a promise of results, but experience in critically evaluating technology, following the evidence, and translating it into more precise decisions for each individual patient.

Read more: Diagnosis and treatment of erectile dysfunction · prostatitis and CP/CPPS

Documentation: This article is based on publicly available event materials and/or LinkedIn posts. Sources: LinkedIn posts